Idiopathic hypereosinophilic syndrome presenting as capsular warning syndrome: A case report and literature review

Medicine (Baltimore). 2023 Sep 8;102(36):e34682. doi: 10.1097/MD.0000000000034682.

Abstract

Rationale: Few reports of idiopathic hypereosinophilic syndrome exist presenting as ischemic cerebrovascular disease, and the majority are watershed infarction. We report the first case of idiopathic hypereosinophilic syndrome that has clinical features of capsular warning syndrome lasting 6 weeks.

Patient concerns: A 26-year-old man complained of recurrent right limb weakness, accompanying slurred speech, and right facial paresthesia.

Diagnoses: The patient was diagnosed with idiopathic hypereosinophilic syndrome (IHES).

Interventions: Adequate glucocorticoid and anticoagulant treatments were given.

Outcomes: The patient's motor ability improved, and he was discharged 2 weeks later. Muscle strength in the right-side extremities had fully recovered at a 3-month follow-up after discharge.

Lessons: This case suggests that idiopathic hypereosinophilic syndrome should be considered as a cause of capsular warning syndrome, and the dose of glucocorticoid and the efficacy evaluation index needs to be reevaluated for the treatment of ischemic cerebrovascular disease associated with idiopathic hypereosinophilic syndrome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anticoagulants
  • Body Fluids*
  • Cerebrovascular Disorders*
  • Glucocorticoids / therapeutic use
  • Humans
  • Hypereosinophilic Syndrome* / complications
  • Hypereosinophilic Syndrome* / diagnosis
  • Hypereosinophilic Syndrome* / drug therapy
  • Male

Substances

  • Glucocorticoids
  • Anticoagulants